1887

Abstract

Introduction:

is a non-fermentative aerobic Gram-negative bacillus, which most frequently causes nosocomial infections. Endocarditis from the pathogen has only rarely been reported and has a near-fatal outcome without surgical intervention.

Case Presentation:

We present a case of endocarditis and septic arthritis in an infant affected by generalized arterial calcification of infancy. The patient was successfully treated with 6 weeks of intravenous colistin, meropenem and trimethoprim/sulfamethoxazole.

Conclusion:

This is the first reported case of colistin used to treat endocarditis. We discuss the antibiotic challenges of treating multidrug-resistant endocarditis in a patient who is not a surgical candidate.

Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.005006
2015-12-13
2020-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/2/6/jmmcr005006.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.005006&mimeType=html&fmt=ahah

References

  1. Abbott I. J., Peleg A. Y.. 2015; Stenotrophomonas, Achromobacter, and nonmelioid Burkholderia species: antimicrobial resistance and therapeutic strategies. Semin Respir Crit Care Med36:99–110 [CrossRef][PubMed]
    [Google Scholar]
  2. Ahn Y., Kim N. H., Shin D. H., Park O. Y., Kim W., Jeong M. H., Cho J. G., Park J. C., Kang J. C.. 2004; Pacemaker lead endocarditis caused by Achromobacter xylosoxidans . J Korean Med Sci19:291–293 [CrossRef][PubMed]
    [Google Scholar]
  3. Biswas S., Dubus J. C., Reynaud-Gaubert M., Stremler N., Rolain J. M.. 2013; Evaluation of colistin susceptibility in multidrug-resistant clinical isolates from cystic fibrosis, France. Eur J Clin Microbiol Infect Dis32:1461–1464[CrossRef]
    [Google Scholar]
  4. Chong C. R., Hutchins G. M.. 2008; Idiopathic infantile arterial calcification: the spectrum of clinical presentations. Pediatr Dev Pathol11:405–415[CrossRef]
    [Google Scholar]
  5. Davis M., Gratten M., Ree G. H.. 1982; Infective endocarditis caused by Actinobacillus actinomycetemcomitans and Achromobacter xylosoxidans . P N G Med J25:7–11[PubMed]
    [Google Scholar]
  6. Derber C., Elam K., Forbes B. A., Bearman G.. 2011; Achromobacter species endocarditis: a case report and literature review. Can J Infect Dis Med Microbiol22:e17–e20
    [Google Scholar]
  7. Dubey L., Krasinski K., Hernanz-Schulman M.. 1988; Osteomyelitis secondary to trauma or infected contiguous soft tissue. Pediatr Infect Dis J7:26–34 [CrossRef][PubMed]
    [Google Scholar]
  8. Edouard T., Chabot G., Miro J., Buhas D. C., Nitschke Y., Lapierre C., Rutsch F., Alos N.. 2011; Efficacy and safety of 2-year etidronate treatment in a child with generalized arterial calcification of infancy. Eur J Pediatr170:1585–1590 [CrossRef][PubMed]
    [Google Scholar]
  9. Farquhar J., Makhseed N., Sargent M., Taylor G., Osiovich H.. 2005; Idiopathic infantile arterial calcification and persistent pulmonary hypertension. Am J Perinatol22:121–125 [CrossRef][PubMed]
    [Google Scholar]
  10. Fort N. M., Aichmair A., Miller A. O., Girardi F. P.. 2014; L5-S1 Achromobacter xylosoxidans infection secondary to oxygen-ozone therapy for the treatment of lumbosacral disc herniation: a case report and review of the literature. Spine39:E413–E416 [CrossRef][PubMed]
    [Google Scholar]
  11. Hoddy D. M., Barton L. L.. 1991; Puncture wound-induced Achromobacter xylosoxidans osteomyelitis of the foot. Am Journal Dis Child145:599–600
    [Google Scholar]
  12. Jacquier H., Le Monnier A., Carbonnelle E., Corvec S., Illiaquer M., Bille E., Zahar J. R., Jaureguy F., other authors. 2012; In vitro antimicrobial activity of “last-resort” antibiotics against unusual nonfermenting Gram-negative bacilli clinical isolates. Microb Drug Resist18:396–401[CrossRef]
    [Google Scholar]
  13. Jeukens J., Freschi L., Kukavica-Ibrulj I., Nguyen D., Levesque R. C.. 2015; Draft genome sequence of triclosan-resistant cystic fibrosis isolate Achromobacter xylosoxidans CF304. Genome Announc3:e00865–15 [CrossRef][PubMed]
    [Google Scholar]
  14. Kalal I. G., Seetha D., Panda A., Nitschke Y., Rutsch F.. 2012; Molecular diagnosis of generalized arterial calcification of infancy (GACI). J Cardiovasc Dis Res3:150–154 [CrossRef][PubMed]
    [Google Scholar]
  15. Karli A., Paksu M. S., Karadag A., Belet N., Paksu S., Guney A. K., Akgun M., Yener N., Sensoy S. G.. 2013; Colistin use in pediatric intensive care unit for severe nosocomial infections: experience of an university hospital. Ann Clin Microbiol Antimicrob12:32 [CrossRef][PubMed]
    [Google Scholar]
  16. Li J. S., Sexton D. J., Mick N., Nettles R., Fowler V. G. Jr, Ryan T., Bashore T., Corey G. R.. 2000; Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis30:633–638 [CrossRef][PubMed]
    [Google Scholar]
  17. Lofgren R. P., Nelson A. E., Crossley K. B.. 1981; Prosthetic valve endocarditis due to Achromobacter xylosoxidans . Am Heart J101:502 [CrossRef][PubMed]
    [Google Scholar]
  18. Malek-Marín T., Arenas M. D., Perdiguero M., Salavert-Lleti M., Moledous A., Cotilla E., Gil M. T.. 2009; A case of endocarditis of difficult diagnosis in dialysis: could pest friends be involved?. Clin Nephrol72:405–409 [CrossRef][PubMed]
    [Google Scholar]
  19. Martino P., Micozzi A., Venditti M., Gentile G., Girmenia C., Raccah R., Santilli S., Alessandri N., Mandelli F.. 1990; Catheter-related right-sided endocarditis in bone marrow transplant recipients. Rev Infect Dis12:250–257 [CrossRef][PubMed]
    [Google Scholar]
  20. McKinley K. P., Laundy T. J., Masterton R. G.. 1990; Achromobacter Group B replacement valve endocarditis. J Infect20:262–263 [CrossRef][PubMed]
    [Google Scholar]
  21. Nanuashvili A., Kacharava G., Jashiashvili N.. 2007; A case of native valve infective endocarditis caused by Alcaligenes xylosoxidans . Eurosurveillance12:E070524
    [Google Scholar]
  22. Olson D. A., Hoeprich P. D.. 1982; Postoperative infection of an aortic prosthesis with Achromobacter xylosoxidans . West J Med136:153–157[PubMed]
    [Google Scholar]
  23. Ozer K., Kankaya Y., Baris R., Bektas C. I., Kocer U.. 2012; Calcaneal osteomyelitis due to Achromobacter xylosoxidans: a case report. J Infect Chemother18:915–918[CrossRef]
    [Google Scholar]
  24. Pamuk G., Aygun D., Barut K., Kasapcopur O.. 2015; Achromobacter causing a thrombophlebitis and osteomyelitis combination: a rare cause. BMJ Case Rep2015:2015[PubMed]
    [Google Scholar]
  25. Rafael A. E., Keshavamurthy S., Sepulveda E., Miranda C. C., Okamoto T., Pettersson G. B.. 2014; Intracardiac abscess with cutaneous fistula secondary to ventricular septal defect repair simulating sternal wound infection. Tex Heart Inst J41:324–326 [CrossRef][PubMed]
    [Google Scholar]
  26. Ramjan K. A., Roscioli T., Rutsch F., Sillence D., Munns C. F.. 2009; Generalized arterial calcification of infancy: treatment with bisphosphonates. Nat Clin Pract Endocrinol Metab5:167–172 [CrossRef][PubMed]
    [Google Scholar]
  27. Rutsch F., Ruf N., Vaingankar S., Toliat M. R., Suk A., Höhne W., Schauer G., Lehmann M., Roscioli T., others. 2003; Mutations in ENPP1 are associated with ‘idiopathic’ infantile arterial calcification. Nat Genet34:379–381 [CrossRef][PubMed]
    [Google Scholar]
  28. Rutsch F., Böyer P., Nitschke Y., Ruf N., Lorenz-Depierieux B., Wittkampf T., Weissen-Plenz G., Fischer R. J., Mughal Z., other authors. 2008; Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy. Circ Cardiovasc Genet1:133–140 [CrossRef][PubMed]
    [Google Scholar]
  29. San Miguel V. V., Lavery J. P., York J. C., Lisse J. R.. 1991; Achromobacter xylosoxidans septic arthritis in a patient with systemic lupus erythematosus. Arthritis Rheum34:1484[CrossRef]
    [Google Scholar]
  30. Sasaki H., Kawai H., Sawamura T., Takiya H.. 1993; [A case report of aortic valve and VSD Dacron patch infective endocarditis after VSD patch closure 15 years ago]. Nihon Kyobu Geka Gakkai Zasshi41:1373–1377 (in Japanese)
    [Google Scholar]
  31. Shaireen H., Howlett A., Amin H., Yusuf K., Kamaluddeen M., Lodha A.. 2013; The mystery of persistent pulmonary hypertension: an idiopathic infantile arterial calcification. BMC Pediatr13:107 [CrossRef][PubMed]
    [Google Scholar]
  32. Stark J. J.. 2007; Alcaligenes xylosoxidans osteomyelitis without trauma in a patient with Good's syndrome. Eur J Intern Med18:447 [CrossRef][PubMed]
    [Google Scholar]
  33. Storey A., Wilson A., McWilliams E.. 2010; Native valve infective endocarditis due to Achromobacter xylosoxidans in an apparently immunocompetent individual. BMJ Case Rep2010:2010[PubMed]
    [Google Scholar]
  34. Suryavanshi K. T., Lalwani S. K.. 2015; Uncommon pathogen: serious manifestation: a rare case of Achromobacter xylosoxidans septic arthritis in immunocompetetant patient. Indian J Pathol Microbiol58:395–397 [CrossRef][PubMed]
    [Google Scholar]
  35. Tokuyasu H., Fukushima T., Nakazaki H., Shimizu E.. 2012; Infective endocarditis caused by Achromobacter xylosoxidans: a case report and review of the literature. Intern Med51:1133–1138 [CrossRef][PubMed]
    [Google Scholar]
  36. van der Sluis I. M., Boot A. M., Vernooij M., Meradji M., Kroon A. A.. 2006; Idiopathic infantile arterial calcification: clinical presentation, therapy and long-term follow-up. Eur J Pediatr165:590–593 [CrossRef][PubMed]
    [Google Scholar]
  37. van Hal S., Stark D., Marriott D., Harkness J.. 2008; Achromobacter xylosoxidans subsp. xylosoxidans prosthetic aortic valve infective endocarditis and aortic root abscesses. J Med Microbiol57:525–527 [CrossRef][PubMed]
    [Google Scholar]
  38. Walsh R. D., Klein N. C., Cunha B. A.. 1993; Achromobacter xylosoxidans osteomyelitis. Clin Infect Dis16:176–178 [CrossRef][PubMed]
    [Google Scholar]
  39. Yabuuchi E., Ohyama A.. 1971; Achromobacter xylosoxidans n. sp. from human ear discharge. Jpn J Microbiol15:477–481 [CrossRef][PubMed]
    [Google Scholar]
  40. Yabuuchi E., Kawamura Y., Kosako Y., Ezaki T.. 1998; Emendation of genus Achromobacter and Achromobacter xylosoxidans (Yabuuchi and Yano) and proposal of Achromobacter ruhlandii (Packer and Vishniac) comb. nov., Achromobacter piechaudii (Kiredjian et al.) comb. nov., and Achromobacter xylosoxidans subsp. denitrificans (Rüger and Tan) comb. nov. Microbiol Immunol42:429–438 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmmcr/10.1099/jmmcr.0.005006
Loading

Most cited this month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error